Commentary on: Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel diseaseSingh H, Nugent Z, Demers AA, Bernstein CN Gastroenterology. 2011;141(5):1612-1620
Questions: Is there an increased risk of nonmelanoma skin cancer (NMSC) for patients with inflammatory bowel disease (IBD)? Is there an increased risk of NMSC if they receive immunosuppressive therapy?
Design: Historical cohort study and nested case-control study.